NCT07450898

Brief Summary

Acute pancreatitis is a rare complication after percutaneous mechanical thrombectomy in treatment of thrombotic disorders. The objectives of this study include: (1) Determine the incidence and severity of acute pancreatitis after percutaneous mechanical thrombectomy; (2) Identify patient/procedural risk factors; (3) Evaluate clinical outcomes; (4) Develop a diagnosis and treatment pathway.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for all trials

Timeline
7mo left

Started Jan 2016

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Jan 2016Dec 2026

Study Start

First participant enrolled

January 1, 2016

Completed
10.2 years until next milestone

First Submitted

Initial submission to the registry

February 27, 2026

Completed
6 days until next milestone

First Posted

Study publicly available on registry

March 5, 2026

Completed
26 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2026

Completed
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

March 5, 2026

Status Verified

March 1, 2026

Enrollment Period

10.3 years

First QC Date

February 27, 2026

Last Update Submit

March 3, 2026

Conditions

Keywords

Thrombectomy

Outcome Measures

Primary Outcomes (1)

  • Incidence of acute pancreatitis

    The incidence of acute pancreatitis within 14 days after mechanical thrombectomy for peripheral thromboembolic disease.

    Within 14 days

Secondary Outcomes (1)

  • Incidence of acute severe pancreatitis

    Within 14 days

Other Outcomes (2)

  • Admission to intensive care unit rate

    Within 60 days

  • All-cause mortality rate

    within 60 days

Study Arms (1)

Acute pancreatitis after percutaneous mechanical thrombectomy group

Patients were diagnosed with acute pancreatitis after percutaneous mechanical thrombectomy in treatment of thrombotic disorders.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with acute pancreatitis after percutaneous mechanical thrombectomy for thrombotic disorders

You may qualify if:

  • Patients over 18 years old;
  • Patients with thrombotic peripheral vascular diseases treated by percutaneous mechanical thrombectomy;
  • Patients developed acute pancreatitis within 14 days after percutaneous mechanical thrombectomy;
  • Patients with written informed consent.

You may not qualify if:

  • Patients with acute pancreatitis attributed to other confirmed causes;
  • Patients unable or unwilling to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Renji Hospital

Shanghai, Shanghai Municipality, 200217, China

RECRUITING

MeSH Terms

Conditions

Pancreatitis

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System Diseases

Study Officials

  • Qihong Ni

    Department of Vascular Surgery, Renji Hospital, School of Medicine, Shanghai Jiao Tong University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 27, 2026

First Posted

March 5, 2026

Study Start

January 1, 2016

Primary Completion

March 31, 2026

Study Completion (Estimated)

December 31, 2026

Last Updated

March 5, 2026

Record last verified: 2026-03

Locations